Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution
about
Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1CSAR benchmark exercise 2011-2012: evaluation of results from docking and relative ranking of blinded congeneric seriesDocking challenge: protein sampling and molecular docking performance.A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition.Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator.Hit clustering can improve virtual fragment screening: CDK2 and PARP1 case studies.Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptorsNew Frontiers in Druggability2-Amidino analogs of glycine-amiloride conjugates: inhibitors of urokinase-type plasminogen activator.A potent and highly efficacious Bcl-2/Bcl-xL inhibitor.Comparative binding energy analysis for binding affinity and target selectivity prediction.Prediction of Positions of Active Compounds Makes It Possible To Increase Activity in Fragment-Based Drug Development.Challenging the gold standard for 3D-QSAR: template CoMFA versus X-ray alignment.Development of antitrypanosomal and antiplasmodial nonpeptidic cysteine protease inhibitors based on N-protected-guanidino-furan and -pyrrole building blocks.Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.Lithium Hexamethyldisilazane Transformation of Transiently Protected 4-Aza/Benzimidazole Nitriles to Amidines and their Dimethyl Sulfoxide Mediated Imidazole Ring Formation.
P2860
Q27666429-61ED1FBC-83B8-4867-B30D-FCC1C6962F08Q30543685-C431A08B-57CE-4EA7-A72D-53365B9C46F9Q30607323-D2BBE357-484C-4014-81C2-487D50EDDEB5Q33222784-A25F716C-9BE7-479A-AC9D-624F11328728Q33233428-0910397D-EFF0-4ADD-BF80-AB279E2E76F9Q34070346-854824D3-81DF-430F-B3BB-06D4E85968DCQ35715070-570A4C5C-EF69-4071-A4BE-2970C3BCFE0DQ35730955-565D0307-8801-436E-B4CE-56A3E8E4C2D3Q35898448-CA1CCD6A-83AA-4513-A7FA-2D239A45203EQ37249666-C89EDE7C-A782-4CD6-AE2C-3205F97EC980Q43273730-8AE0E051-8BDA-4C4A-B0A5-44DF72C8AF10Q46065964-E7C1533E-F672-4E64-930C-5D2A01CA0585Q46627471-162C22CC-C791-4208-9884-AAC62C19AA9FQ47982718-6D3805ED-F284-492A-B61E-4F040E517BA7Q50728831-464D3F57-313F-4578-A69D-F787845CDF7CQ50763462-C1B4BFD5-0367-4CBB-9638-AC05F41156D6
P2860
Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Identification of novel bindin ...... N-phenyl amide 6-substitution
@ast
Identification of novel bindin ...... N-phenyl amide 6-substitution
@en
Identification of novel bindin ...... N-phenyl amide 6-substitution
@nl
type
label
Identification of novel bindin ...... N-phenyl amide 6-substitution
@ast
Identification of novel bindin ...... N-phenyl amide 6-substitution
@en
Identification of novel bindin ...... N-phenyl amide 6-substitution
@nl
prefLabel
Identification of novel bindin ...... N-phenyl amide 6-substitution
@ast
Identification of novel bindin ...... N-phenyl amide 6-substitution
@en
Identification of novel bindin ...... N-phenyl amide 6-substitution
@nl
P2093
P356
P1476
Identification of novel bindin ...... N-phenyl amide 6-substitution
@en
P2093
Andrew Geyer
Michael D Wendt
Moshe Weitzberg
Robert Mantei
Todd W Rockway
Vered Klinghofer
Vicki L Nienaber
Vincent L Giranda
William McClellan
Xumiao Zhao
P304
P356
10.1021/JM0300072
P407
P577
2004-01-01T00:00:00Z